87.39 USD
↘ 1.68 (1.89%)AT CLOSE (11:59 AM EDT)
Inhibrx Biosciences, Inc. Common Stock
INBXNASDAQ • USD
88.00
↗ 0.61 (0.70%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
88.00
↗ 0.61 (0.70%)
Market: CLOSED
INBX is currently priced at $87.08. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (618.9%) and a bullish Golden Cross on the moving averages. Furthermore, INBX is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Jul 17, 2026.
Open?$86.68
High?$91.52
Low?$85.21
Prev. Close?$89.07
Volume?272.1K
Avg. Volume?354.0K
VWAP?$89.02
Rel. Volume?0.77x
Bid / Ask
Bid?$75.34 × 100
Ask?$103.74 × 100
Spread?$28.40
Midpoint?$89.54
Valuation & Ratios
Market Cap?1.3B
Shares Out?14.7M
Float?9.3M
Float %?63.3%
P/E Ratio?N/A
P/B Ratio?-62.12
EPS?-$8.87
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Themes
Employees
110
Market Cap
1.3B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-05-28
Address
11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037
Phone: (858) 795-4220
LA JOLLA, CA 92037
Phone: (858) 795-4220
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?5
Momentum?50
Short Sent.?16
Piotroski F-Score?0/9Weak
Altman Z-Score?0.44Distress
Confidence?54%Low
Short InterestSqueeze Risk
Short % of Float?37.09%Squeeze Risk
Short Interest?3.4M
Days to Cover?9.9
Free Float9.3M
Avg Daily Volume347.7K
Settlement Date2026-06-30
Financial Health
Current Ratio?6.46Strong
Quick Ratio?6.46Strong
Cash Ratio?6.10Strong
Debt/Equity?-8.32Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-62.12CHEAP▾
S&P97
P/S?1,005.20HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-10.9CHEAP▾
S&P97
EV/Sales?1,015.46HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?618.9%STRONG▾
Peers50
S&P97
ROA?-70.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-131935000
Enterprise Value?$1.3B
Fundamentals ratios updated end of day